Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Julian Friebel(Humboldt-Universität zu Berlin), Ursula Rauch(Charité - Universitätsmedizin Berlin), Michael Gotthardt(Max Delbrück Center), Max Wegner(Charité - Universitätsmedizin Berlin), Konstantinos Savvatis(Interbalkan Medical Center), Verena Moos(Charité - Universitätsmedizin Berlin), Dirk Laßner, Stephan B. Felix(Universitätsmedizin Greifswald), Peter Bobbert(Franziskus-Krankenhaus Berlin), Heinz-Peter Schutheiss(CS Diagnostics), Alice Weithäuser(Johannes Gutenberg University Mainz), Ulf Landmesser(University of Zurich), Termeh Tabaraie(Johannes Gutenberg University Mainz), Bernhard H. Rauch(University of Washington), Carsten Tschöpe(Franklin University), Michaël Radkë(Max Delbrück Center), Diana Bösel(Charité - Universitätsmedizin Berlin), Marco Witkowski(Cleveland Clinic), Mario Kašner(Charité - Universitätsmedizin Berlin), Andrea Dörner(Charité - Universitätsmedizin Berlin)
Cited by 60
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k